Atlas Trials

Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis

Clinical trial NCT07246759 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07246759
Sponsor
OncoHost Ltd.
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Non Small Cell Lung Cancer (NSCLC)Melanoma (Skin Cancer)Triple Negative Breast Cancer (TNBC)RCC, Renal Cell CancerHNSCC
Start date
2025-11-15
Primary completion
2027-09-30
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.